The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures. - Biology of Cardiovascular Diseases Accéder directement au contenu
Article Dans Une Revue Cardiovascular Diabetology Année : 2024

The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures.

Résumé

Chen et al. recently related the skin autofluorescence (SAF) of Advanced Glycation End-products to subclinical cardiovascular disease in the 3001 participants from the general population (Rotterdam study), with a particularly close relationship for the 413 subjects with diabetes. Because conventional vascular risk factors do not capture the risk in diabetes very well, this relationship may help to select high-risk individuals for the screening of silent myocardial ischemia, which has yet to prove its benefit in randomized controlled trials. Among 477 patients with uncontrolled and/or complicated Type 2 Diabetes, we measured the SAF ten years ago, and we registered new revascularizations during a 54-months follow-up. The patients with SAF > 2.6 Arbitrary units (AUs), the median population value, experienced more revascularizations of the coronary (17/24) and lower-limb arteries (13/17) than patients with a lower SAF, adjusted for age, sex, diabetes duration, vascular complications, and smoking habits: HR 2.17 (95% CI: 1.05-4.48), p = 0.035. The SAF has already been reported to predict cardiovascular events in three cohorts of people with diabetes. We suggest that its measurement may help to improve the performance of the screening before vascular explorations and revascularizations.
Fichier principal
Vignette du fichier
BMC_Cardiovasc.Diabetol._2024_Alkhami.pdf (667.15 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04424606 , version 1 (29-01-2024)

Licence

Identifiants

Citer

Fadi Alkhami, Gauthier Borderie, Ninon Foussard, Alice Larroumet, Laurence Blanco, et al.. The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures.. Cardiovascular Diabetology, 2024, 23 (1), pp.32. ⟨10.1186/s12933-024-02121-5⟩. ⟨hal-04424606⟩

Collections

CNRS U1219 U1034
23 Consultations
10 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More